SCHEMBL7452382

SCHEMBL7452382

COC(=O)c1cc(OCCO)ccc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.56
ALDH1A1 P00352 5/20 0.56
MAPT P10636 4/20 0.56
HSD17B10 Q99714 4/20 0.56
GAA P10253 3/20 0.56
HPGD P15428 3/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
CFTR P13569 2/20 0.47
GLA P06280 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
ATM Q13315 1/20 0.44
ABL1 P00519 2/20 0.43
RAB9A P51151 1/20 0.42
MTNR1A P48039 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL267612 0.88 ALDH1A1 (0.56) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL4257305 0.88 ALDH1A1 (0.56) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL13163934 0.87 ALDH1A1 (0.55) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL1012515 0.87 KDM4E (0.55) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL13740239 0.84 ALDH1A1 (0.59) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL30710211 0.84 MAPT (0.52) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL13163935 0.84 KDM4E (0.52) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL7452118 0.84 BRAF (0.50) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL23758029 0.83 ALDH1A1 (0.51) KDM4EALDH1A1MAPTHSD17B10GAA
SCHEMBL13163939 0.83 ALDH1A1 (0.51) KDM4EALDH1A1MAPTHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A KDM4E 2322/4885ALDH1A1 271/4885MAPT 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.